Skip to main content
. Author manuscript; available in PMC: 2024 Feb 1.
Published in final edited form as: Brain Res. 2022 Nov 30;1800:148189. doi: 10.1016/j.brainres.2022.148189

Figure 3:

Figure 3:

Effect of mifepristone pre-treatment and corticosterone treatment on protein expression in ventral hippocampus as measured by western immunoblot (A) Corticosterone but not mifepristone treatment increased OCT3 expression. Mifepristone but not corticosterone treatment increased SERT (B) and GR expression (C). Means expressed as percentage of control, data in the graphs represent Mean ± SEM; *indicates significant difference between groups, P< 0.05.

OCT3 expression is upregulated by corticosterone in the ventral hippocampus

Mifepristone treatment increases SERT and GR expression in the ventral hippocampus

Regulation of OCT3 expression in the ventral hippocampus is altered by corticosterone